• Artelo Biosciences announced a private placement for 3,188,407 common shares (or pre-funded warrants) and warrants to buy up to 6,376,814 shares at a combined purchase price of USD 3.45 per share.
• The offering is expected to raise about USD 11.0 million in gross proceeds, before fees and expenses.
• Warrants have an exercise price of USD 3.20 per share and expire 5.5 years from the effectiveness date of a resale registration statement.
• Net proceeds are intended for working capital, general corporate purposes, and repayment of certain bridge debt.
• The securities were offered in an unregistered private placement under Section 4(a)(2) and/or Regulation D, with a resale registration statement to be filed under a registration rights agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief on March 27, 2026, and is solely responsible for the information contained therein.